Co-Diagnostics, Inc. Accounts Receivable, before Allowance for Credit Loss, Current
Co-Diagnostics, Inc. (CODX) had Accounts Receivable, before Allowance for Credit Loss, Current of $92.99 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableGrossCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Receivable, before Allowance for Credit Loss, Current $92.99K.
- 2026-03-31: Accounts Receivable, before Allowance for Credit Loss, Current $126.88K.
- 2025-12-31: Accounts Receivable, before Allowance for Credit Loss, Current $230.75K.
- 2025-09-30: Accounts Receivable, before Allowance for Credit Loss, Current $101.97K.
| Period end | Accounts Receivable, before Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $92.99K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $126.88K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $230.75K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $101.97K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $297.99K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $240.81K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $242.63K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $384.64K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $710.90K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $620.55K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $504.26K 10-K · filed 2026-03-31 |
| 2023-09-30 | $4.23M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.51M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.69M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.55M 10-K · filed 2025-03-27 |
| 2022-09-30 | $8.97M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $12.94M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $22.38M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $21.51M 10-K · filed 2023-03-16 |
| 2021-09-30 | $15.35M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $13.69M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $12.99M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $12.93M 10-K · filed 2022-03-24 |
| 2020-09-30 | $11.50M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $5.89M 10-Q/A · filed 2020-11-03 |
| 2020-03-31 | $1.10M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $142.38K 10-K · filed 2021-03-25 |
| 2019-09-30 | $77.68K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $73.11K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |